comprehensive -WSS

comprehensive

author：explore 2025-08-12 08:29:34 - browse：41733

MultiPlan is facing a new class action lawsuit that alleges the company and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims.

The lawsuit, filed by for-profit hospital company Allegiance Health Management, builds on the contentious relationship between hospitals and MultiPlan, a data technology vendor that works with the biggest insurers to determine how much should be paid for care that is delivered outside of an insurance network. It comes just weeks after the New York Times published an investigation detailing how MultiPlan and its insurance company clients make more money by low-balling payments to hospitals.

The lawsuit further lays bare some of the warped incentives that exist within the health care system: out-of-network providers billing inflated amounts, insurers profiting by making sure those payments are as low as possible, and patients stuck in the middle with bills they often cannot afford.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Getting Alzheimer's drug Leqembi to patients can be a challenge

leisure time

WSS

Intellia reports positive results for its CRISPR

Health care needs a new profession: neuroimaging counseling

Element Biosciences CEO lays out genome sequencing strategy

Ionis drug prevents swelling attacks due to hereditary angioedema

Diversity in clinical trials starts with building trust, experts say

FDA's Pazdur wants cancer trials to range beyond China alone

knowledge

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Medical records are filled with copy

After traumatic brain injury, life support decisions can use more time

Apple is now the first public company to be valued at $3 trillion

BMI, flaws aside, is found to be useful estimate of body fat in youth

Virginia high school admissions case could be legal follow

How to increase colonoscopy rates? Looks like an AI can help

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Woman returns to dialysis after doctors remove transplanted pig kidney

Trump demands the U.S. pay no more for drugs than other countries … again

Q&A: Jennifer Adair on making gene therapy available globally

Wikipedia

Woman returns to dialysis after doctors remove transplanted pig kidney

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Let's speed up science by embracing open access publishing

Getting Alzheimer's drug Leqembi to patients can be a challenge

Bird flu outbreak in cows is latest avian flu curveball

Exact Sciences stock tumbles despite strong cancer detection sales

leisure time

hotspot

focus

Wikipedia